data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Acorda Therapeutics
(NASDAQ:ACOR)
$0.6272
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$0.612
-0.0152[-2.42%]
PreMarket: 5:32PM EDT
Day Range- - -52 Wk Range0.26 - 2.83Open / Close- / -Float / Outstanding24.2M / 24.3M
Vol / Avg.- / 3.9MMkt Cap15.3MP/E-50d Avg. Price0.54
Div / Yield-Payout Ratio-Total Float24.2MEPS-0.57

Acorda Therapeutics Stock (NASDAQ:ACOR), Quotes and News Summary

Acorda Therapeutics Stock (NASDAQ: ACOR) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range0.26 - 2.83Open / Close- / -Float / Outstanding24.2M / 24.3M
Vol / Avg.- / 3.9MMkt Cap15.3MP/E-50d Avg. Price0.54
Div / Yield-Payout Ratio-Total Float24.2MEPS-0.57
Business Wire - Nov 11, 2022, 9:52AM
Business Wire - Nov 4, 2022, 9:25AM
Business Wire - Nov 1, 2022, 4:01PM
Business Wire - Oct 27, 2022, 7:00AM
Business Wire - Oct 25, 2022, 4:01PM
Business Wire - Oct 21, 2022, 7:00AM
Business Wire - Oct 19, 2022, 7:00AM
Business Wire - Oct 18, 2022, 7:00AM
PRNewswire - Oct 17, 2022, 11:51AM
Business Wire - Oct 16, 2022, 4:48PM
PRNewswire - Oct 10, 2022, 9:38AM
Business Wire - Oct 10, 2022, 6:30AM
Business Wire - Sep 8, 2022, 4:01PM
Business Wire - Aug 29, 2022, 7:00AM
Business Wire - Aug 19, 2022, 8:00AM
Business Wire - Aug 4, 2022, 4:01PM
Business Wire - Jul 28, 2022, 4:01PM
PRNewswire - Jun 16, 2022, 9:00AM
Business Wire - Jun 16, 2022, 7:01AM
Business Wire - May 11, 2022, 4:01PM
Business Wire - May 11, 2022, 4:01PM
Business Wire - May 4, 2022, 4:01PM
Business Wire - Mar 9, 2022, 4:01PM
Business Wire - Feb 24, 2022, 5:00PM
Business Wire - Jan 4, 2022, 7:11AM
Business Wire - Jan 3, 2022, 4:01PM
Seeking Alpha - Nov 1, 2022, 7:49PM
InvestorsObserver - Nov 1, 2022, 1:11PM
Seeking Alpha - Oct 27, 2022, 1:43PM
InvestorsObserver - Oct 20, 2022, 1:57PM
InvestorsObserver - Oct 19, 2022, 2:12PM
InvestorsObserver - Oct 17, 2022, 10:12AM
Seeking Alpha - Oct 17, 2022, 7:53AM
InvestorsObserver - Oct 10, 2022, 12:37PM
Seeking Alpha - Oct 10, 2022, 7:53AM
InvestorsObserver - Oct 4, 2022, 1:48PM
InvestorsObserver - Oct 3, 2022, 11:59AM
InvestorsObserver - Sep 22, 2022, 12:13PM
InvestorsObserver - Sep 20, 2022, 1:11PM
TalkMarkets - Sep 3, 2022, 3:40PM
Seeking Alpha - Aug 29, 2022, 7:20AM
Seeking Alpha - Aug 7, 2022, 11:42AM
InvestorsObserver - Aug 5, 2022, 11:49AM
Seeking Alpha - Aug 3, 2022, 5:35PM
InvestorsObserver - Jun 16, 2022, 1:09PM
Seeking Alpha - Jun 16, 2022, 1:02PM
InvestorsObserver - May 25, 2022, 12:07PM
InvestorsObserver - May 23, 2022, 11:58AM
InvestorsObserver - May 20, 2022, 1:47PM
InvestorsObserver - May 19, 2022, 11:53AM
InvestorsObserver - May 13, 2022, 10:47AM
Seeking Alpha - May 11, 2022, 8:22PM
Seeking Alpha - May 11, 2022, 4:16PM
Sector: Health Care.Industry: Biotechnology
Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.550
REV36.970M33.511M-3.459M
Q2 2022Est.ActualSurprise
EPS-3.150
REV36.970M31.051M-5.919M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Acorda Therapeutics (ACOR) stock?

A

You can purchase shares of Acorda Therapeutics (NASDAQ: ACOR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acorda Therapeutics's (ACOR) competitors?

Q

What is the target price for Acorda Therapeutics (ACOR) stock?

A

The latest price target for Acorda Therapeutics (NASDAQ: ACOR) was reported by HC Wainwright & Co. on Thursday, June 17, 2021. The analyst firm set a price target for 10.00 expecting ACOR to rise to within 12 months (a possible 1494.39% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acorda Therapeutics (ACOR)?

A

The stock price for Acorda Therapeutics (NASDAQ: ACOR) is $0.6272 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Acorda Therapeutics (ACOR) pay a dividend?

A

There are no upcoming dividends for Acorda Therapeutics.

Q

When is Acorda Therapeutics (NASDAQ:ACOR) reporting earnings?

A

Acorda Therapeutics’s Q3 earnings are confirmed for Tuesday, November 1, 2022.

Q

Is Acorda Therapeutics (ACOR) going to split?

A

There is no upcoming split for Acorda Therapeutics.

Q

What sector and industry does Acorda Therapeutics (ACOR) operate in?

A

Acorda Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.